Adverse effects of rifampin.

J. Grosset, S. Leventis

Research output: Contribution to journalArticle

Abstract

Rifampin has proved to be a valuable antibiotic with relatively few major adverse effects. Its toxicity is predominantly hepatic and immunoallergic in character. While hepatic toxicity is dose related and has been observed mainly in patients with underlying liver disease, the immunoallergic effects are usually associated with intermittent or prolonged therapy. These immunoallergic effects may be minor (a cutaneous, gastrointestinal, or influenzalike syndrome) or major (hemolytic anemia, shock, or acute renal failure).

Original languageEnglish (US)
JournalReviews of Infectious Diseases
Volume5 Suppl 3
StatePublished - Jul 1983
Externally publishedYes

Fingerprint

Rifampin
Liver
Hemolytic Anemia
Acute Kidney Injury
Liver Diseases
Shock
Anti-Bacterial Agents
Skin
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Grosset, J., & Leventis, S. (1983). Adverse effects of rifampin. Reviews of Infectious Diseases, 5 Suppl 3.

Adverse effects of rifampin. / Grosset, J.; Leventis, S.

In: Reviews of Infectious Diseases, Vol. 5 Suppl 3, 07.1983.

Research output: Contribution to journalArticle

Grosset, J & Leventis, S 1983, 'Adverse effects of rifampin.', Reviews of Infectious Diseases, vol. 5 Suppl 3.
Grosset J, Leventis S. Adverse effects of rifampin. Reviews of Infectious Diseases. 1983 Jul;5 Suppl 3.
Grosset, J. ; Leventis, S. / Adverse effects of rifampin. In: Reviews of Infectious Diseases. 1983 ; Vol. 5 Suppl 3.
@article{9cfdb9f0d8774a24892e872be6451a69,
title = "Adverse effects of rifampin.",
abstract = "Rifampin has proved to be a valuable antibiotic with relatively few major adverse effects. Its toxicity is predominantly hepatic and immunoallergic in character. While hepatic toxicity is dose related and has been observed mainly in patients with underlying liver disease, the immunoallergic effects are usually associated with intermittent or prolonged therapy. These immunoallergic effects may be minor (a cutaneous, gastrointestinal, or influenzalike syndrome) or major (hemolytic anemia, shock, or acute renal failure).",
author = "J. Grosset and S. Leventis",
year = "1983",
month = "7",
language = "English (US)",
volume = "5 Suppl 3",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Adverse effects of rifampin.

AU - Grosset, J.

AU - Leventis, S.

PY - 1983/7

Y1 - 1983/7

N2 - Rifampin has proved to be a valuable antibiotic with relatively few major adverse effects. Its toxicity is predominantly hepatic and immunoallergic in character. While hepatic toxicity is dose related and has been observed mainly in patients with underlying liver disease, the immunoallergic effects are usually associated with intermittent or prolonged therapy. These immunoallergic effects may be minor (a cutaneous, gastrointestinal, or influenzalike syndrome) or major (hemolytic anemia, shock, or acute renal failure).

AB - Rifampin has proved to be a valuable antibiotic with relatively few major adverse effects. Its toxicity is predominantly hepatic and immunoallergic in character. While hepatic toxicity is dose related and has been observed mainly in patients with underlying liver disease, the immunoallergic effects are usually associated with intermittent or prolonged therapy. These immunoallergic effects may be minor (a cutaneous, gastrointestinal, or influenzalike syndrome) or major (hemolytic anemia, shock, or acute renal failure).

UR - http://www.scopus.com/inward/record.url?scp=0020789493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020789493&partnerID=8YFLogxK

M3 - Article

C2 - 6356277

VL - 5 Suppl 3

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

ER -